1 / 16

Global Biological Drugs Market is Estimated to Reach $394 Billion by 2024, Says Variant Market Research

Global Biological Drugs Market is estimated to reach $394 billion by 2024; growing at a CAGR of 10.3% from 2016 to 2024. Biological drugs are complex molecules manufactured by using living plant or animal cells or micro-organisms. They include a wide range of products derived from animals, humans or microorganisms by using biotechnology. Unlike other drugs,

Download Presentation

Global Biological Drugs Market is Estimated to Reach $394 Billion by 2024, Says Variant Market Research

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Global Biological Drugs Market is Estimated to Reach $394 Billion by 2024, Says Variant Market Research GeetanjaliRaut SEO Executive Variant Market Research

  2. sales@variantmarketresearch.com |help@variantmarketresearch.com Global Biological Drugs Market Global Biological Drugs Market is estimated to reach $394 billion by 2024; growing at a CAGR of 10.3% from 2016 to 2024. Biological drugs are complex molecules manufactured by using living plant or animal cells or micro-organisms. They include a wide range of products derived from animals, humans or microorganisms by using biotechnology. Unlike other drugs, biologic products must remain constant by quality and purity throughout the process as they are highly sensitive to very minute changes during the process. Hence, it is very essential for the biological drugs to be manufactured in very controlled environment to ensure predictable outcomes. Moreover, biological drugs have aided in altering the treatment of many serious and chronic illnesses to a great extent. They are one of the most advanced therapies available and have the ability to treat cancer, ulcerative colitis, rheumatoid arthritis, and other autoimmune diseases. Browse Complete Report @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/biological-drugs-market

  3. sales@variantmarketresearch.com |help@variantmarketresearch.com Global Biological Drugs Market Size and Forecast, 2015 – 2024.

  4. Biological Drugs Market The global biological drugs market is categorized into product type and geography. By product type, the market is segmented into therapeutic protein (Enbrel, Lantus, Neulasta, Avones, Novolog, Rebif, Humalog, Aranesp, Epogen, Levemir, Victoza, Betaseron, Neupogen, Eylea And Others), monoclonal antibody (Humira, Remicade, Rituxan, Avastin, Herceptin, Lucentis, And Others) and vaccine (Prevnar 13, Gardasil, Fluzone, Varivax, Cervarix, And Others).Get sample report @ https://www.variantmarketresearch.com/report-categories/pharmaceuticals/biological-drugs-market/sample-request sales@variantmarketresearch.com |help@variantmarketresearch.com

  5. sales@variantmarketresearch.com |help@variantmarketresearch.com Global Biological Drugs market share by region, 2024

  6. Top Manufacturers sales@variantmarketresearch.com |help@variantmarketresearch.com Baxter International Inc. Bristol-Myers Squibb Company, Merck & Co., Inc., Amgen Inc.,  Biogen Inc.,  GlaxoSmithKline Plc, Novartis AG, Eli Lilly and Co.,  Pfizer Inc., Abbott Laboratories,

  7. sales@variantmarketresearch.com |help@variantmarketresearch.com • The key takeaways from the report • Comprehensive analysis of market dynamics including factors and opportunities will be provided in the report • An exhaustive regional analysis of Global Biological Drugs Market from 2015 to 2024 has been included in the report • The report will include the qualitative and quantitative analysis with market estimation over 2015-2024 and compound annual growth rate (CAGR) between 2016 and 2024 • Profile of the key players in the Global Biological Drugs Market will be provided, which include key financials, product & services, new developments and business strategies • The report will provide a detailed analysis of Global Biological Drugs Market with respect to major segments such as product type and geography

  8. sales@variantmarketresearch.com |help@variantmarketresearch.com • Scope of the Global Biological Drugs Market • Product Type Segments • Therapeutic Protein • Enbrel • Lantus • Neulasta • Avones • Novolog • Rebif • Humalog • Aranesp • Epogen • Levemir • Victoza • Betaseron • Neupogen • Eylea • Other Therapeutic Proteins

  9. sales@variantmarketresearch.com |help@variantmarketresearch.com • Scope of the Global Biological Drugs Market • Monoclonal Humira • Remicade • Rituxan • Avastin • Herceptin • Lucentis • Other Monoclonal Antibodies • Prevnar 13 • Gardasil • Fluzone • Varivax • Cervarix • Other Vaccines

  10. sales@variantmarketresearch.com |help@variantmarketresearch.com • Scope of the Global Biological Drugs Market • Geography Segments • North America • U.S. • Canada • Mexico • Europe • UK • Germany • France • Italy • Others

  11. sales@variantmarketresearch.com |help@variantmarketresearch.com Scope of the Global Biological Drugs Market • Asia-Pacific • India • China • Japan • South Korea • Others • RoW • South America • Middle East • Africa

  12. sales@variantmarketresearch.com |help@variantmarketresearch.com Table Of Content Chapter 1 Prefix 1.1 Market Scope 1.2 Report Description 1.3 Research Methodology 1.3.1 Primary Research 1.3.2 Secondary Research 1.3.3 In-house Data Modeling Chapter 2 Executive Summary

  13. sales@variantmarketresearch.com |help@variantmarketresearch.com Table Of Content Chapter 3 Market Outline 3.1 Market Inclination, Trend, Outlook and Viewpoint 3.2 Market Share Analysis: Company’s Competitive Scenario 3.3 Value Chain Analysis 3.4 Market Dynamics 3.4.1 Drivers 3.4.1.1 Impact Analysis 3.4.2 Restraints 3.4.2.1 Impact Analysis 3.4.3 Opportunities 3.5 Porter’s five forces analysis 3.5.1 Factors Impact Analysis ………..

  14. sales@variantmarketresearch.com |help@variantmarketresearch.com Table Of Content Chapter 6 Company Profiles 6.1 Baxter International Inc. 6.2 Bristol-Myers Squibb Company 6.3 Merck & Co., Inc. 6.4 Amgen Inc. 6.5 Biogen Inc. 6.6 GlaxoSmithKline Plc 6.7 Novartis AG 6.8 Eli Lilly and Co. 6.9 Pfizer Inc. 6.10 Abbott Laboratories

  15. Contact Us sales@variantmarketresearch.com |help@variantmarketresearch.com Variant Market Research LLP. Website: https://www.variantmarketresearch.com USA Office: 649 Mission St, 5th Floor, San Francisco, CA 94105, United States. Tel: +1-415-680-2785 Fax: +1-415-680-2786 Email: help@variantmarketresearch.com Follow Us: LinkedIn | Facebook | Twitter | Google +

  16. sales@variantmarketresearch.com |help@variantmarketresearch.com Thank You Follow Us….

More Related